These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11569892)

  • 21. [Treatment of familial amyloid polyneuropathy].
    Adams D; Samuel D; Slama M
    Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transthyretin Ile73Val is associated with familial amyloidotic polyneuropathy in a Bangladeshi family. Mutations in brief no. 158. Online.
    Booth DR; Gillmore JD; Persey MR; Booth SE; Cafferty KD; Tennent GA; Madhoo S; Cochrane SW; Whitehead TC; Pasvol G; Hawkins PN
    Hum Mutat; 1998; 12(2):135. PubMed ID: 10694917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial].
    Ando Y
    Rinsho Byori; 2000 May; 48(5):425-9. PubMed ID: 10892290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.
    Masuda T; Ueda M; Suenaga G; Misumi Y; Tasaki M; Izaki A; Yanagisawa Y; Inoue Y; Motokawa H; Matsumoto S; Mizukami M; Arimura A; Deguchi T; Nishio Y; Yamashita T; Inomata Y; Obayashi K; Ando Y
    Neurology; 2017 Jun; 88(23):2192-2197. PubMed ID: 28490654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family studies of the genetic abnormality in transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy.
    Saraiva MJ; Birken S; Costa PP; Goodman DS
    Ann N Y Acad Sci; 1984; 435():86-100. PubMed ID: 6099706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Variable clinical manifestations of familial amyloid polyneuropathy and living related liver transplantation].
    Ikeda S; Yanagisawa N
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1433-5. PubMed ID: 8752421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Said G
    Lancet Neurol; 2011 Dec; 10(12):1086-97. PubMed ID: 22094129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.
    Conceição I; González-Duarte A; Obici L; Schmidt HH; Simoneau D; Ong ML; Amass L
    J Peripher Nerv Syst; 2016 Mar; 21(1):5-9. PubMed ID: 26663427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
    Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
    Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Lalu T; Misrahi M; Reilly MM; Adams D; Lacroix C; Said G
    Neurology; 1998 Sep; 51(3):708-14. PubMed ID: 9748014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Protein and DNA sequencing analyses of transthyretin in familial amyloidotic polyneuropathy].
    Nakazato M
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1436-7. PubMed ID: 8752422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
    Sattianayagam PT; Hahn AF; Whelan CJ; Gibbs SD; Pinney JH; Stangou AJ; Rowczenio D; Pflugfelder PW; Fox Z; Lachmann HJ; Wechalekar AD; Hawkins PN; Gillmore JD
    Eur Heart J; 2012 May; 33(9):1120-7. PubMed ID: 21992998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Demonstration of genetic mutation in most of the amyloid neuropathies with sporadic occurrence].
    Adams D; Reilly M; Harding AE; Said G
    Rev Neurol (Paris); 1992; 148(12):736-41. PubMed ID: 1338934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels.
    Terazaki H; Ando Y; Misumi S; Nakamura M; Ando E; Matsunaga N; Shoji S; Okuyama M; Ideta H; Nakagawa K; Ishizaki T; Ando M; Saraiva MJ
    Biochem Biophys Res Commun; 1999 Oct; 264(2):365-70. PubMed ID: 10529370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid neuropathy with transthyretin mutations: overview and unique Ala97Ser in Taiwan.
    Hsieh ST
    Acta Neurol Taiwan; 2011 Jun; 20(2):155-60. PubMed ID: 21739396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation for hereditary transthyretin amyloidosis.
    Suhr OB; Herlenius G; Friman S; Ericzon BG
    Liver Transpl; 2000 May; 6(3):263-76. PubMed ID: 10827225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and future treatment of amyloid neuropathies.
    Adams D; Cauquil C; Theaudin M; Rousseau A; Algalarrondo V; Slama MS
    Expert Rev Neurother; 2014 Dec; 14(12):1437-51. PubMed ID: 25416603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Familial amyloid neuropathies].
    Julien J
    Rev Neurol (Paris); 1993; 149(10):517-23. PubMed ID: 8023063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of amyloid neuropathy in Europe.
    Holt IJ; Harding AE; Middleton L; Chrysostomou G; Said G; King RH; Thomas PK
    Lancet; 1989 Mar; 1(8637):524-6. PubMed ID: 2564060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis.
    Obici L; Kuks JB; Buades J; Adams D; Suhr OB; Coelho T; Kyriakides T;
    Curr Opin Neurol; 2016 Feb; 29 Suppl 1(Suppl 1):S27-35. PubMed ID: 26734953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.